TrueBlue, Inc.
corporate_fare Company Profile
TrueBlue, Inc. (NYSE:TBI) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 22 items for TBI at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-04, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 16 rated 8 or above. Recent SEC coverage for TBI spans 8-K, 10-Q, 144, DEF 14A.
Recent high-impact activity:
- TrueBlue Q3 Revenue Jumps 21% to $521M, Swings to $0.28 EPS; Guides Q4 to $499M-$519M
- TrueBlue Swings to $9M Profit as Revenue Jumps 21% to $521M
- TrueBlue's Q2 revenue climbs 12%, but margin erosion and impairment charges weigh on the bottom line
- TrueBlue Q2 Revenue Jumps 12%, Adjusted EBITDA Surges to $11M; Guides Q3 Revenue Above Consensus
- Director Files Intent to Sell Shares Valued at $204.9 Million
Financial Snapshot
Short Interest & Short Volume
2.30 days to coverFINRA reported short interest of 449,533 shares in TBI as of the October 30, 2026 settlement, a 6.0% increase from the prior period — about 2.3 days to cover at its recent average daily volume. On November 20, 2026, 37.9% of TBI volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.